Stock Watch / by - 3 months ago

CSL back in the buy zone

15 Jun 2020 - Fairmont Equities managing director Michael Gable takes a technical look S&P500, CSL, Resmed Inc and Bravura Solutions.

Company News / by Rachael Jones - 9 months ago

CSL (ASX:CSL) update their R&D

04 Dec 2019 - Biotech company CSL (ASX:CSL) is advancing its Research & Development (R&D) pipeline and capabilities to deliver a highly differentiated product portfolio mix, addres…